Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA): a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial

Medizin & Biologie

• Cicatrix 4%
• Clinical Trials 3%
• Dysmenorrhea 6%
• Dyspnea 4%
• Endometriosis 5%
• Enoxaparin 21%
• Factor Xa Inhibitors 7%
• Germany 4%
• Hemorrhage 3%
• Infarction 4%
• Intention 5%
• Lower Extremity 4%
• Menorrhagia 21%
• Microcirculation 5%
• Pain 12%
• Pain Measurement 10%
• Patient Compliance 5%
• Pharmaceutical Preparations 2%
• Population 2%
• Rivaroxaban 100%
• Safety 3%
• Skin 5%
• Skin Diseases 5%
• Tablets 5%
• Therapeutics 8%
• Thrombosis 4%
• University Hospitals 4%
• Visual Analog Scale 10%